Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −558 $21.00 $12K 88,013
2026-05-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −559 $22.24 $12K 88,571
2026-05-15 Basso Stephen Chief Financial Officer Grant or award +1,123 89,130
2026-05-04 Basso Stephen Chief Financial Officer Grant or award +37,994 88,007
2026-05-04 Basso Stephen Chief Financial Officer Grant or award · Non-statutory Stock Option +93,750 93,750
2026-02-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −1,244 $23.39 $29K 50,013
2025-11-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −237 $21.16 $5K 51,257
2025-11-15 Basso Stephen Chief Financial Officer Grant or award +604 51,494
2025-11-03 Basso Stephen Chief Financial Officer Grant or award +27,609 $18.11 $500K 50,890
2025-08-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −237 $19.95 $5K 23,281
2025-05-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −237 $18.78 $4K 23,518
2025-05-15 Basso Stephen Chief Financial Officer Grant or award +1,353 23,755
2025-02-24 Basso Stephen Chief Financial Officer Grant or award +10,569 $18.08 $191K 22,402
2025-02-24 Basso Stephen Chief Financial Officer Grant or award · Non-statutory Stock Option +100,831 276,730
2025-02-20 Basso Stephen Chief Financial Officer Shares withheld for taxes −1,106 $18.07 $20K 11,833
2024-11-15 Basso Stephen Chief Financial Officer Grant or award +843 12,939
2024-03-05 Basso Stephen Chief Financial Officer Grant or award +12,096 $14.88 $180K 12,096
2024-03-05 Basso Stephen Chief Financial Officer Grant or award · Non-statutory Stock Option +25,899 175,899
2023-08-31 Basso Stephen Chief Financial Officer Grant or award · Nonqualified Stock Option +150,000 150,000

Page 1 of 1 · 19 trades